Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities LTRN - Lantern Pharma Inc.
-930 K
LAST VALUE
78.18%
2 YEAR CAGR
-181.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR